| pubmed-article:4038295 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:4038295 | lifeskim:mentions | umls-concept:C0007090 | lld:lifeskim |
| pubmed-article:4038295 | lifeskim:mentions | umls-concept:C0020281 | lld:lifeskim |
| pubmed-article:4038295 | lifeskim:mentions | umls-concept:C0027021 | lld:lifeskim |
| pubmed-article:4038295 | lifeskim:mentions | umls-concept:C0030011 | lld:lifeskim |
| pubmed-article:4038295 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:4038295 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:4038295 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:4038295 | pubmed:dateCreated | 1985-10-17 | lld:pubmed |
| pubmed-article:4038295 | pubmed:abstractText | N-Hydroxy-N-2-fluorenylacetamide, a proximate carcinogenic metabolite of N-2-fluorenylacetamide, is oxidized largely to 2-nitrosofluorene by lactoperoxidase or extract of peroxidative activity of rat uterus in an H2O2- and Br- -dependent reaction. Evidence is presented that the oxidizing species includes OBr- (HOBr). This novel oxidation may be involved in carcinogenesis by N-arylhydroxamic acids. | lld:pubmed |
| pubmed-article:4038295 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:language | eng | lld:pubmed |
| pubmed-article:4038295 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:4038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:4038295 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:4038295 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:4038295 | pubmed:issn | 0006-291X | lld:pubmed |
| pubmed-article:4038295 | pubmed:author | pubmed-author:Malejka-Gigan... | lld:pubmed |
| pubmed-article:4038295 | pubmed:author | pubmed-author:RitterC LCL | lld:pubmed |
| pubmed-article:4038295 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:4038295 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:4038295 | pubmed:volume | 131 | lld:pubmed |
| pubmed-article:4038295 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:4038295 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:4038295 | pubmed:pagination | 174-81 | lld:pubmed |
| pubmed-article:4038295 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:meshHeading | pubmed-meshheading:4038295-... | lld:pubmed |
| pubmed-article:4038295 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:4038295 | pubmed:articleTitle | A novel oxidation of the carcinogen N-hydroxy-N-2-fluorenylacetamide catalyzed by peroxidase/H2O2/Br-. | lld:pubmed |
| pubmed-article:4038295 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:4038295 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:4038295 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
